Literature DB >> 23341589

RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.

Guoxin Liang1, Kouichi Kitamura, Zhe Wang, Guangyan Liu, Sajeda Chowdhury, Weixin Fu, Miki Koura, Kousho Wakae, Tasuku Honjo, Masamichi Muramatsu.   

Abstract

Activation-induced cytidine deaminase (AID) is essential for the somatic hypermutation (SHM) and class-switch recombination (CSR) of Ig genes. The mechanism by which AID triggers SHM and CSR has been explained by two distinct models. In the DNA deamination model, AID converts cytidine bases in DNA into uridine. The uridine is recognized by the DNA repair system, which produces DNA strand breakages and point mutations. In the alternative model, RNA edited by AID is responsible for triggering CSR and SHM. However, RNA deamination by AID has not been demonstrated. Here we found that C-to-T and G-to-A mutations accumulated in hepatitis B virus (HBV) nucleocapsid DNA when AID was expressed in HBV-replicating hepatic cell lines. AID expression caused C-to-T mutations in the nucleocapsid DNA of RNase H-defective HBV, which does not produce plus-strand viral DNA. Furthermore, the RT-PCR products of nucleocapsid viral RNA from AID-expressing cells exhibited significant C-to-T mutations, whereas viral RNAs outside the nucleocapsid did not accumulate C-to-U mutations. Moreover, AID was packaged within the nucleocapsid by forming a ribonucleoprotein complex with HBV RNA and the HBV polymerase protein. The encapsidation of the AID protein with viral RNA and DNA provides an efficient environment for evaluating AID's RNA and DNA deamination activities. A bona fide RNA-editing enzyme, apolipoprotein B mRNA editing catalytic polypeptide 1, induced a similar level of C-to-U mutations in nucleocapsid RNA as AID. Taken together, the results indicate that AID can deaminate the nucleocapsid RNA of HBV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23341589      PMCID: PMC3568302          DOI: 10.1073/pnas.1221921110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  APOBEC-mediated editing of viral RNA.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Michael H Malim
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 4.  The AID dilemma: infection, or cancer?

Authors:  Tasuku Honjo; Maki Kobayashi; Nasim Begum; Ai Kotani; Somayeh Sabouri; Hitoshi Nagaoka
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

Review 5.  Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model.

Authors:  T I Michalak
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

6.  Fidelity of DNA polymerases in DNA amplification.

Authors:  P Keohavong; W G Thilly
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination.

Authors:  Tomomitsu Doi; Kazuo Kinoshita; Masaya Ikegawa; Masamichi Muramatsu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

8.  AID mutant analyses indicate requirement for class-switch-specific cofactors.

Authors:  Van-Thanh Ta; Hitoshi Nagaoka; Nadia Catalan; Anne Durandy; Alain Fischer; Kohsuke Imai; Shigeaki Nonoyama; Junko Tashiro; Masaya Ikegawa; Satomi Ito; Kazuo Kinoshita; Masamichi Muramatsu; Tasuku Honjo
Journal:  Nat Immunol       Date:  2003-08-10       Impact factor: 25.606

9.  AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.

Authors:  Ahmad Faili; Said Aoufouchi; Quentin Guéranger; Carole Zober; Anne Léon; Barbara Bertocci; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Nat Immunol       Date:  2002-07-29       Impact factor: 25.606

10.  Oligomer synthesis by priming deficient polymerase in hepatitis B virus core particle.

Authors:  Hee-Young Kim; Gil-Soon Park; Eung-Goo Kim; Seung-Hyun Kang; Ho-Joon Shin; Sun Park; Kyongmin Hwang Kim
Journal:  Virology       Date:  2004-04-25       Impact factor: 3.616

View more
  28 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

2.  Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.

Authors:  Guangyan Liu; Xiancai Ma; Zhe Wang; Kousho Wakae; Yaochang Yuan; Zhangping He; Hironori Yoshiyama; Hisashi Iizasa; Hui Zhang; Mami Matsuda; Ryuichi Sugiyama; Zhiyu Yuan; Masamichi Muramatsu; Linghua Li
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

3.  Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.

Authors:  Xiaoming Cheng; Takuro Uchida; Yuchen Xia; Regina Umarova; Chun-Jen Liu; Pei-Jer Chen; Anuj Gaggar; Vithika Suri; Marcus M Mücke; Johannes Vermehren; Stefan Zeuzem; Yuji Teraoka; Mitsutaka Osawa; Hiroshi Aikata; Keiji Tsuji; Nami Mori; Shuhei Hige; Yoshiyasu Karino; Michio Imamura; Kazuaki Chayama; T Jake Liang
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.

Authors:  Ziwei Yin; Maki Kobayashi; Wenjun Hu; Koichi Higashi; Nasim A Begum; Ken Kurokawa; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-08       Impact factor: 11.205

6.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

Authors:  S Kondo; K Wakae; N Wakisaka; Y Nakanishi; K Ishikawa; T Komori; M Moriyama-Kita; K Endo; S Murono; Z Wang; K Kitamura; T Nishiyama; K Yamaguchi; S Shigenobu; M Muramatsu; T Yoshizaki
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

Review 7.  Generation and repair of AID-initiated DNA lesions in B lymphocytes.

Authors:  Zhangguo Chen; Jing H Wang
Journal:  Front Med       Date:  2014-04-21       Impact factor: 4.592

8.  APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.

Authors:  Zhe Wang; Kousho Wakae; Kouichi Kitamura; Satoru Aoyama; Guangyan Liu; Miki Koura; Ahasan M Monjurul; Iwao Kukimoto; Masamichi Muramatsu
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells.

Authors:  Eric L Fritz; Brad R Rosenberg; Kenneth Lay; Aleksandra Mihailović; Thomas Tuschl; F Nina Papavasiliou
Journal:  Nat Immunol       Date:  2013-05-26       Impact factor: 25.606

10.  Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma.

Authors:  Xiaowei Ji; Qi Zhang; Yan Du; Wenbin Liu; Zixiong Li; Xiaomei Hou; Guangwen Cao
Journal:  Curr Genomics       Date:  2014-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.